Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report

BACKGROUND: Metabolic syndrome (MS) is known to be associated with hypertension, insulin resistance, and dyslipidemia, and it raises the risk for cardiovascular diseases and diabetes mellitus. Telmisartan is used in clinic as an angiotensin II receptor blocker and it is also identified as activating...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Kai-Chun, Li, Yingxiao, Chang, Wei-Ting, Kuo, Feng Yu, Chen, Zhih-Cherng, Cheng, Juei-Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290862/
https://www.ncbi.nlm.nih.gov/pubmed/30584345
http://dx.doi.org/10.2147/DMSO.S187092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290862/
https://www.ncbi.nlm.nih.gov/pubmed/30584345
http://dx.doi.org/10.2147/DMSO.S187092

Ejemplares similares